Navigation Links
Nausea Drug Shows Promise Against Opioid Addiction
Date:2/18/2009

Ondansetron relieves withdrawal symptoms without side effects, early study shows

WEDNESDAY, Feb. 18 (HealthDay News) -- A drug currently used to treat nausea can prevent symptoms of withdrawal from illegal and prescription opioid drugs such as heroin, morphine and codeine, a new study shows.

The Stanford University scientists behind the research added it can do so without some of the serious side effects caused by existing treatments for addiction to these drugs.

Initial tests in mice showed that the drug ondansetron (Zofran) blocks certain 5-HT3 receptors involved in withdrawal symptoms, the researchers said. They then tested it in eight healthy, non-opioid-dependent volunteers who were given two doses of morphine, once without ondansetron and one with it, and found ondansetron reduced withdrawal symptoms in humans.

The study appears in the Feb. 17 online issue of the Journal of Pharmacogenetics and Genomics.

"Opioid abuse is rising at a faster rate than any other type of illicit drug use, yet only about a quarter of those dependent on opioids seek treatment. One barrier to treatment is that when you abruptly stop taking the drugs, there is a constellation of symptoms associated with withdrawal," lead author Dr. Larry F. Chu, an assistant professor of anesthesia, said in a Stanford news release.

Those symptoms include agitation, insomnia, diarrhea, nausea and vomiting. Current methods of treating withdrawal symptoms aren't completely effective or cause severe side effects, requiring constant patient supervision.

"What we need is a magic bullet, something that treats the symptoms of withdrawal, does not lead to addiction and can be taken at home," Chu added.

The Stanford team plans to continue testing the effectiveness of ondansetron in treating opioid addiction and to conduct a clinical study to determine the effectiveness of an ondansetron-like drug in treating opioi
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

2

GOOD

Page: 1 2

Related medicine news :

1. Oncologists Rank Aloxis Marketing Message Most Influential in the Chemotherapy-Induced Nausea and Vomiting Drug Market
2. SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Chemotherapy Patients, Now Available
3. FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
4. Explaining chemotherapy-associated nausea
5. Mayo Clinic study finds FDA warning against antinausea drug droperidol unnecessary
6. Acupuncture does not reduce radiotherapy-induced nausea, but patients believe it does
7. No Link Between Anti-Nausea Drug, Heart Trouble
8. HotHead Technologies Heat Sensor Shows Exciting Potential by Kennesaw State University Researchers
9. Partnership for Prevention: CDC Report Shows Compelling Need for FDA Regulation of Tobacco
10. New CDC Study Shows Tobacco Marketing Influences Kids to Smoke, Underscores Need for FDA Regulation of Tobacco Products
11. Caregivers not receiving the help they need, study shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nausea Drug Shows Promise Against Opioid Addiction
(Date:5/24/2013)... (PRWEB) May 24, 2013 Gift ... Cards, major competitors in sustainable card material, are ... using forest materials as a sustainable gift card ... to identify industry challenges and increase education and ... programs to support the reduction of carbon footprint ...
(Date:5/24/2013)... 2013 Started in 1982, AMTC’s SHINE event ... 2013 marks AMTC’s 31st anniversary. SHINE is a ministry run ... Millie Lewis and her daughter, Carey Lewis Arban. , This ... directors, and music professionals including the New York Film Academy, ... They are kings of Hollywood and Christian casting directors. They ...
(Date:5/24/2013)... replicate what appeared to be breakthrough results for the ... last year in the journal Science . , ... the drug bexarotene (marketed as Targretin) could rapidly reverse ... pathological hallmark of Alzheimer,s disease in the brains ... report, drug treatment quickly removed most of the plaques ...
(Date:5/24/2013)... Salt Lake City, Utah (PRWEB) May 24, 2013 ... AnatomyOne 2.0 , with exciting new enhancements for instructors ... help students stay more focused through personalize learning plan ... the new AnatomyOne release provides 500 new assessment questions, ... make and review notes. , AnatomyOne 2.0 ...
(Date:5/24/2013)... Los Angeles, CA (PRWEB) May 24, 2013 ... is to present the 3rd Annual EB-5 Investment Summit: ... 2013. The Dealmakers Conference will focus on exploring alternative ... provide the latest market, legal and economic information, and ... legal professionals within the EB-5 industry. , "Our ...
Breaking Medicine News(10 mins):Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2
... claim against City of New York and New York City Police ... ... 2008 -- http://thesandersfirm.com/attorney.asp?attorneyid=14 [Marc Grossman], senior partner of leading ... & Grossman, P.C. in Bronx, New York, today announced that his ...
... Inc. (PST) (OTC Bulletin Board: PSTX) announced today that ... a first closing of a,private placement. The proceeds will ... Medical subsidiary. Investors in the first,closing of the private ... a price of $1.25 per share and received a ...
... 27 Replidyne, Inc.,(Nasdaq: RDYN ) today ... employee headcount by approximately 80% to 5 employees ... September 2008 and October,2008. As a result of ... REP3123, its investigational agent for the,treatment of Clostridium ...
... will gain access to innovative medical, education and ... satellite, radio channel created for medical professionals by ... XM 157 announced today a new,strategic programming partnership ... oldest and largest, independent,association for physicians-in-training., Gary ...
... long known that teens are less likely than other ... from the Meharry-State Farm Alliance at Meharry Medical College ... passengers may be an even bigger problem. , In ... driver and passenger seat belt use for a nationally ...
... to make insulin-resistant proteins, study says , , WEDNESDAY, Aug. 27 ... compared to those in lean people, a new study shows. ... , a group of researchers from the Temple University School ... six lean and six obese people. , They found significant ...
Cached Medicine News:Health News:New York-Based Sanders Law Firm Files Claim for Good Samaritan Beaten by New York City Police Officers 2Health News:Patient Safety Technologies Closes on $2.325 Million in Equity Financing 2Health News:Replidyne Announces Restructuring of Operations 2Health News:ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association 2Health News:ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association 3Health News:Teens making poor choices when it comes to riding in vehicles 2
(Date:5/23/2013)... 2013 More than half of women diagnosed ... chemotherapy and still have excellent outcomes. To educate women, ... the largest sources of online consumer information about breast ... page provide recently diagnosed women with information sources, to ... "We anticipate these innovative social media campaigns ...
(Date:5/23/2013)... Mich. , May 23, 2013  Every day, their ... of air to his lungs. April and Bryan ... dire predictions weren,t true. "Quite a few doctors ... hospital alive," says April Gionfriddo , about ... desperate. Anything that would work, we would take it and ...
(Date:5/23/2013)... 2013  Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company ... today announced that it has initiated dosing in a ... daily, oral therapy for the treatment of HCV infection. This ... is designed to assess both the safety and antiviral ... drug for the treatment of chronic HCV infections and ...
Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3
... Cambridge Temperature Concepts (CTC), the company behind the ... I Award by the Wireless-Life Sciences Alliance (WLSA) ... . DuoFertility uses wireless technology to predict when ovulation will ... possible chance of conceiving naturally. News of this win follows ...
... Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ... in China based on the number of directly operated ... first quarter ended March 31, 2011. ... Revenue increased by 9.0% to RMB618.1 million (US$94.4 ...
Cached Medicine Technology:Cambridge Temperature Concepts Wins Prestigious Award From the Wireless-Life Sciences Alliance for Fertility Monitor DuoFertility 2Cambridge Temperature Concepts Wins Prestigious Award From the Wireless-Life Sciences Alliance for Fertility Monitor DuoFertility 3Cambridge Temperature Concepts Wins Prestigious Award From the Wireless-Life Sciences Alliance for Fertility Monitor DuoFertility 4China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 2China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 3China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 4China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 5China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 6China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 7China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 8China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 9
A simple solution to hand assisted laparoscopic surgery....
... The HandPort Systems non-adhesive ... during Hand-Assisted Laparoscopic Surgrery (HALS) ... touch, grasp, and palpate throughout. ... small as 6 cm, patients ...
... 200 series offers a range of ... The design delivers therapy to meet ... promote results in commercial and clinical ... differentiator in the SleepStyle 200 series ...
The SleepStyle 600 series with ThermoSmart delivers humidification with anti-rainout benefits. ThermoSmart technology offers a heated breathing tube that allows the constant delivery of optimal level...
Medicine Products: